TY - JOUR
T1 - Use of Smoking Cessation Methods among Patients Receiving Office-based Buprenorphine Maintenance Treatment
AU - Shah, Pooja A.
AU - Cunningham, Chinazo O.
AU - Brisbane, Mia T.
AU - Deluca, Joseph P.
AU - Nahvi, Shadi
N1 - Funding Information:
From the University of California, San Francisco School of Medicine, San Francisco, CA (PAS); Albert Einstein College of Medicine & Montefiore Medical Center, Bronx, NY (COC, MTB, JPD, SN). Received for publication March 16, 2017; accepted August 14, 2017. Funding: This work was supported by the National Institutes of Health (K23DA025736, K24DA036955, R25DA023021, R01DA032110, and R34DA031066). The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The authors report no conflicts of interest. Send correspondence to Shadi Nahvi, MD, MS, 111 E. 210th Street, Bronx, NY 10467. E-mail: snahvi@montefiore.org Copyright © 2017 American Society of Addiction Medicine ISSN: 1932-0620/17/1106-0494 DOI: 10.1097/ADM.0000000000000356
Publisher Copyright:
© 2017 American Society of Addiction Medicine.
PY - 2017
Y1 - 2017
N2 - Objectives: Provision of smoking-cessation treatment is limited in office-based buprenorphine maintenance treatment (BMT) settings. This study describes smoking and smoking-cessation behaviors among patients receiving office-based BMT. Methods: Cross-sectional study of patients receiving office-based BMT at a community health center in the Bronx, NY. We interviewed patients assessing sociodemographic, and substance use and tobacco use characteristics, including methods used for smoking cessation. We reported simple frequencies and explored associations of BMT characteristics with smoking behaviors. Results: Of 68 patients, 87.7% were current cigarette smokers, 7.9% were former smokers, and 4.4% had never smoked. Of lifetime smokers, 83.1% reported at least 1 prior quit attempt, and 78.5% had used medication (75.4% used nicotine replacement therapy, 29.2% varenicline, and 9.2% bupropion). Ten patients (15.4%) reported using electronic cigarettes to try to quit smoking. Stopping "cold Turkey" (40.0%) and gradually decreasing the number of cigarettes smoked (32.3%) were nonpharmacological methods of quitting tried most often. Use of behavioral support, including stop-smoking programs and counseling, was low. Higher dose and longer duration of BMT was associated with greater smoking frequency. Conclusions: Patients receiving BMT have a high prevalence of cigarette smoking, though most have tried to quit, and have prior experience with pharmacotherapy for smoking cessation. Efforts to optimize smoking-cessation treatments among BMT patients are needed.
AB - Objectives: Provision of smoking-cessation treatment is limited in office-based buprenorphine maintenance treatment (BMT) settings. This study describes smoking and smoking-cessation behaviors among patients receiving office-based BMT. Methods: Cross-sectional study of patients receiving office-based BMT at a community health center in the Bronx, NY. We interviewed patients assessing sociodemographic, and substance use and tobacco use characteristics, including methods used for smoking cessation. We reported simple frequencies and explored associations of BMT characteristics with smoking behaviors. Results: Of 68 patients, 87.7% were current cigarette smokers, 7.9% were former smokers, and 4.4% had never smoked. Of lifetime smokers, 83.1% reported at least 1 prior quit attempt, and 78.5% had used medication (75.4% used nicotine replacement therapy, 29.2% varenicline, and 9.2% bupropion). Ten patients (15.4%) reported using electronic cigarettes to try to quit smoking. Stopping "cold Turkey" (40.0%) and gradually decreasing the number of cigarettes smoked (32.3%) were nonpharmacological methods of quitting tried most often. Use of behavioral support, including stop-smoking programs and counseling, was low. Higher dose and longer duration of BMT was associated with greater smoking frequency. Conclusions: Patients receiving BMT have a high prevalence of cigarette smoking, though most have tried to quit, and have prior experience with pharmacotherapy for smoking cessation. Efforts to optimize smoking-cessation treatments among BMT patients are needed.
KW - buprenorphine
KW - community health center
KW - nicotine use disorder
KW - opioid use disorder
KW - smoking cessation
UR - http://www.scopus.com/inward/record.url?scp=85033798675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85033798675&partnerID=8YFLogxK
U2 - 10.1097/ADM.0000000000000356
DO - 10.1097/ADM.0000000000000356
M3 - Article
C2 - 28885300
AN - SCOPUS:85033798675
SN - 1932-0620
VL - 11
SP - 494
EP - 497
JO - Journal of addiction medicine
JF - Journal of addiction medicine
IS - 6
ER -